U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic ​skin disease met the main goal ‌in a mid-stage study.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermati
Black Swift Group LLC acquired a new stake in shares of Pfizer Inc. (NYSE: PFE) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commis
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
First Trust Advisors LP raised its stake in shares of Pfizer Inc. (NYSE: PFE) by 4.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Th
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
U.S. considers global AI chip export restrictions, impacting Nvidia and AMD as shares fall on regulatory risk. A 30-day U.S. waiver allows India to purchase stranded Russian crude, aiming to stabilize
China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ​management in overweight or obese adults, the ‌US drugmaker said on WeChat on Friday, boosting competition in a market
A federal judge on Thursday awarded Pfizer $29 million to resolve a ​dispute with the U.S. Securities and Exchange ‌Commission stemming from the regulator's 2013 insider trading settlement with bi
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?
PFE faces falling COVID sales, looming patent cliffs and IRA pressure. It is betting on cost cuts, new launches and pipeline rebuilds to revive growth.
Teva Pharmaceutical is a bit of a turnaround story, as the company continues a major business overhaul. This competitor, with a huge 6.3% yield, has hit a few setbacks, but it is still just business a

Seven S&P500 Ideal 'Safer' March Dividend Dogs

11:31am, Wednesday, 04'th Mar 2026
Seven S&P 500 dividend 'Dogs'—including VICI, VZ, BEN, F, HST, T, and KEY—offer high yields supported by sufficient free cash flow, making them attractive buys. Analyst forecasts project 14.2% to
Pfizer's portfolio renewal is in progress, with new launches and acquisitions driving +14.6% YoY growth in new product revenues, though legacy drug expiries may pressure intermediate-term sales. These
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the N
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE